Drawing for BIOLOGICA

USPTO serial 99859338

BIOLOGICA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ESPINOZA, JALYN NMN
Law office
TMO LAW OFFICE 139

What this means

Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.

Status 638: Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months.

Need help with BIOLOGICA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eleanor M. Lackman

Eleanor M. Lackman Mitchell Silberberg & Knupp LLP437 Madison Avenue, 25th FloorNew York, NY 10022United States

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplements for women, namely, multivitamin-based preparations in powder form used to improve mood balance, energy, metabolism, digestion, and sleep conditions at multiple life stagesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026DOCKASSIGNED TO EXAMINER—
Oct 4, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 2, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 2, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance